gefitinib has been researched along with 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide) | Trials (2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide) | Recent Studies (post-2010) (2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 63 | 0 | 51 |
| Protein | Taxonomy | gefitinib (IC50) | 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide (IC50) |
|---|---|---|---|
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 0.0189 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.02 | |
| Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Q; Chen, X; Du, Y; Hou, J; Nan, J; Wang, Q; Wang, Y; Yang, J; Zhang, J; Zhang, X; Zhu, N | 1 |
1 other study(ies) available for gefitinib and 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide
| Article | Year |
|---|---|
TPCA-1 is a direct dual inhibitor of STAT3 and NF-κB and regresses mutant EGFR-associated human non-small cell lung cancers.
Topics: Amides; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Mutation; NF-kappa B; Quinazolines; Signal Transduction; STAT3 Transcription Factor; Thiophenes | 2014 |